Table 1.
Characteristics | SNRPD1 level | ||||
---|---|---|---|---|---|
N | high(n) | low(n) | *P-Value | ||
Gender | Male | 211 | 103 | 108 | 0.336 |
Female | 31 | 18 | 13 | ||
Age | >55 | 75 | 32 | 43 | 0.126 |
<=55 | 167 | 89 | 78 | ||
Tumor size | >5cm | 88 | 46 | 42 | 0.559 |
<=5cm | 153 | 74 | 79 | ||
TNM stage | I/II | 176 | 83 | 93 | 0.025 |
III | 49 | 32 | 17 | ||
Serum AFP level | >300ng/ml | 110 | 73 | 37 | <0.001 |
<=300ng/ml | 128 | 47 | 81 | ||
ALT | >50U/L | 100 | 49 | 51 | 0.794 |
<=50U/L | 142 | 72 | 70 | ||
BCLC staging | Yes | 225 | 115 | 110 | 0.746 |
0-A | 173 | 86 | 87 | ||
B-C | 52 | 29 | 23 | ||
CLIP staging | 0 | 98 | 36 | 62 | <0.001 |
1-5 | 127 | 79 | 48 | ||
Multinodular | Yes | 51 | 29 | 22 | 0.270 |
No | 191 | 92 | 99 | ||
Cirrhosis | Yes | 19 | 12 | 7 | 0.232 |
No | 223 | 109 | 114 |
Abbreviations: AFP - alpha fetoprotein, TNM - tumor, node, metastasis; ALT, alanine aminotransferase. BCLC, Barcelona Clinic Liver Cancer. *P-Value<0.05 were considered statistically significant.